Illumina’s New State of the art Manufacturing Facility

February 7, 2019

Opening in Q2, 2019 the Madison, WI site is a 133,000 SF purpose-built GMP facility that has been designed and constructed for Illumina’s Enzyme Manufacturing. Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on